Portal de Periódicos da CAPES

Mood Disorder in Women with Early Breast Cancer Taking Tamoxifen, an Estradiol Receptor Antagonist

1995; Wiley; Volume: 761; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1995.tb31394.x

1749-6632

Salima Shariff, C. E. Cumming, Alan Lees, Michael Handman, David C. Cumming,

Phytoestrogen effects and research

Annals of the New York Academy of SciencesVolume 761, Issue 1 p. 365-368 Mood Disorder in Women with Early Breast Cancer Taking Tamoxifen, an Estradiol Receptor Antagonist An Expected or Unexpected Effect? S. SHARIFF, S. SHARIFF University of Alberta and Cross Cancer Institute Edmonton, Alberta, Canada T6G 2R7Search for more papers by this authorC. E. CUMMING, C. E. CUMMING University of Alberta and Cross Cancer Institute Edmonton, Alberta, Canada T6G 2R7Search for more papers by this authorA. LEES, A. LEES University of Alberta and Cross Cancer Institute Edmonton, Alberta, Canada T6G 2R7Search for more papers by this authorM. HANDMAN, M. HANDMAN University of Alberta and Cross Cancer Institute Edmonton, Alberta, Canada T6G 2R7Search for more papers by this authorD. C. CUMMING, Corresponding Author D. C. CUMMING University of Alberta and Cross Cancer Institute Edmonton, Alberta, Canada T6G 2R7Correspondence to: David C. dimming, 1D1 Mackenzie Health Sciences Centre, University of Alberta, Edmonton, Alberta, Canada T6G 2R7.Search for more papers by this author S. SHARIFF, S. SHARIFF University of Alberta and Cross Cancer Institute Edmonton, Alberta, Canada T6G 2R7Search for more papers by this authorC. E. CUMMING, C. E. CUMMING University of Alberta and Cross Cancer Institute Edmonton, Alberta, Canada T6G 2R7Search for more papers by this authorA. LEES, A. LEES University of Alberta and Cross Cancer Institute Edmonton, Alberta, Canada T6G 2R7Search for more papers by this authorM. HANDMAN, M. HANDMAN University of Alberta and Cross Cancer Institute Edmonton, Alberta, Canada T6G 2R7Search for more papers by this authorD. C. CUMMING, Corresponding Author D. C. CUMMING University of Alberta and Cross Cancer Institute Edmonton, Alberta, Canada T6G 2R7Correspondence to: David C. dimming, 1D1 Mackenzie Health Sciences Centre, University of Alberta, Edmonton, Alberta, Canada T6G 2R7.Search for more papers by this author First published: June 1995 https://doi.org/10.1111/j.1749-6632.1995.tb31394.xCitations: 35AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Love, R. R., L. Cameron, B. L. Connell & H. Levanthal, 1991. Symptoms associated with tamoxifen treatment in postmenopausal women. Arch. Intern. Med. 151: 1842–1847. 2 Schipper, H., J. Clinch, A. McMurray & M. Levitt, 1984. Measuring the quality of life of cancer patients: functional living index. J. Clin. Oncol. 2: 472–483. 3 Watson, M. S. Greer, L. Rowden, C Gorman, B. Robertson, J. M. Bliss & R. Tunmore 1991. Relationships between emotional control, adjustment to cancer and depression and anxiety in breast cancer patients. Psychol. Med. 21: 51–57. 4 Lansky, S. B., M. A. List, C. A. Herrman, E. G. Ets-Hokin, T. K. DasGupta, G. D. Wilbanks & F. R. Hendrickson, 1985. Absence of major depressive disorder in female cancer patients. J. Clin. Oncol. 11: 1553–1560. 5 Cathcart, C. H., S. E. Jones, C. S. Pumroy, G. N. Peters, S. M. Knox & J. H. Cheek 1993. Clinical recognition and management of depression in node negative breast cancer patients treated with tamoxifen. Breast Cancer Res. Treat. 27: 277–281. Citing Literature Volume761, Issue1Steroid Receptors and AntihormonesJune 1995Pages 365-368 ReferencesRelatedInformation